Oxford Instruments plc ("the Company"), a global provider of high technology products and services to many of the world's leading companies and scientific research communities, today announces succession plans for the role of Chief Financial Officer ("CFO") to the Company. After nearly nine years with the Company, Gavin Hill has agreed with the Board that [...]

Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of Directors Zürich, Switzerland – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025. Pascal Behr, Ph.D., co-founder and CEO for 12 years, remains on the [...]

CIQTEK, a leading manufacturer in the field of optical and electron microscopy, has recently entered into a strategic partnership with JH Technologies, a renowned distributor in North America. This collaboration aims to focus on providing cutting-edge scanning electron microscopes (SEMs) to customers across the region while enhancing the profile of CIQTEK. With 37 years of extensive experience delivering microscopy and [...]

ATCC will provide lab services including immunological and virological assays, and reagent and viral stock preparation to support the Animal Models and Retroviral Vaccines Section within the National Cancer Institute’s Vaccine Branch MANASSAS, Va. -- ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a five-year, Indefinite [...]

Powered by Elegen's patented cell-free linear DNA synthesis technology, ENFINIA™ Plasmid DNA slashes lead times from months to weeks at an affordable price. SAN CARLOS, Calif. – Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis of long and complex genes. ENFINIA Plasmid [...]

Vienna, Austria – Regulatory automation provider Platomics has announced a strategic pilot program with Agilent Technologies Inc. (NYSE: A) to enhance laboratory documentation capabilities for next-generation sequencing (NGS) tests under the European Union’s In Vitro Diagnostic Regulation (IVDR). This collaboration enables Agilent customers to leverage Platomics’ PlatoX® platform for generating comprehensive documentation required for IVDR [...]

— Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members. The SAB will provide technical and strategic guidance for ongoing research and development programs and shape plans for [...]

SAN JOSE, Calif. -- In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions. Expanding U.S. manufacturing capabilities in 2024 and beyond After weathering a year of geopolitical [...]

SAN DIEGO - Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, [...]

ALAMEDA, Calif. -- CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited cells for biotech and pharmaceutical [...]